Pattern of Pharmacotherapy and Glycemic Control Status in Diabetic Patients with Different Stages of CKD in A Tertiary Care Centre in Kerala
Abstract
Background: Type 2 Diabetes Mellitus (T2DM) is a leading cause of Chronic Kidney Disease (CKD), with approximately 20–30% of diabetic patients developing moderate-to-severe renal impairment. Management of diabetes in CKD is clinically challenging due to altered insulin metabolism, reduced renal clearance of anti-diabetic drugs, and increased risk of both hyperglycemia and hypoglycemia. Although guidelines such as ADA, KDIGO, and KDOQI recommend an HbA1c target of
Fields of Study & Subjects
Chronic Kidney Disease and Diabetes
Diabetes Treatment and Management
Diabetes Management and Research
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 26 February 2026
- Language
- EN